eae36, a locus on mouse chromosome 4, controls susceptibility to experimental allergic encephalomyelitis in older mice and mice immunized in the winter

Genetics

Volumn 172, Issue 2, 2006, Pages 1147-1153

  Teuscher, Cory ^a   Doerge, R W ^b   Fillmore, Parley D ^c   Blankenhorn, Elizabeth P ^d  

^a UNIVERSITY OF VERMONT   (United States)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CHROMOSOME 4; CONTROLLED STUDY; GENE LOCUS; GENE MAPPING; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENOME; IMMUNIZATION; IMMUNOGENETICS; LINKAGE ANALYSIS; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SEASON; SPRING; WINTER;

AGING; ANIMALS; CROSSES, GENETIC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; IMMUNIZATION; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEASONS;

ANIMALIA;

EID: 33644781695     PISSN: 00166731     EISSN: 00166731     Source Type: Journal    
DOI: 10.1534/genetics.105.049049     Document Type: Article

References (72)

1. AGHAJANIAN, G. K., and E. SANDERS-BUSH, 2002 Serotonin, pp. 15-34 in Neuropsychopharmacology: The Fifth Generation of Progress, edited by K. L. DAVIS, D. CHARNEY, J. T. COYLE and C. NEMEROFF. Lippencott Williams & Wilkins, Philadelphia.
2. AZZIMONDI, G., A. STRACCIARI, R. RINALDI, R. D'ALESSANDRO and P. PAZZAGLIA, 1994 Multiple sclerosis with very late onset: report of six cases and review of the literature. Eur. Neurol. 34: 332-336.
3. BERKAHN, L., and A. KEATING, 2004 Hematopoiesis in the elderly. Hematology 9: 159-163.
4. BLANKENHORN, E. P., R. J. BUTTERFIELD, R. RIGBY, L. CORT, D. GIAMBRONE et al., 2000 Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: an environmental agent can override genetic checkpoints. J. Immunol. 164: 3420-3425.
5. BREWERTON, T. D., 1989 Seasonal variation of serotonin function in humans: research and clinical implications. Ann. Clin. Psychiatry 1: 153-164.
6. BUTTERFIELD, R. J., J. D. SUDWEEKS, E.P. BLANKENHORN, R. KORNGOLD, J. C. MARINI et al., 1998 New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 161: 1860-1867.
7. CHEN, J., L. LIU and B. POHAJDAK, 1995 Cloning a cDNA from human NK/T cells which codes for a protein with high proline content. Biochim. Biophys. Acta 1264: 19-22.
8. CHURCHILL, G. A., and R. W. DOERGE, 1994 Empirical threshold values for quantitative trait mapping. Genetics 138: 963-971.
9. COHEN, Z., G. BONVENTO, P. LACOMBE and E. HAMEL, 1996 Serotonin in the regulation of brain microcirculation. Prog. Neurobiol. 50: 335-362.
10. COMPSTON, A., and A. COLES, 2002 Multiple sclerosis. Lancet 359: 1221-1231.
11. COMPSTON, A., and S. SAWCER, 2003 Genetic analysis of multiple sclerosis in Europeans (GAMES). J. Neuroimmunol. 143: 1-139.
12. COO, H., and K. J. ARONSON, 2004 A systematic review of several potential non-genetic risk factors for multiple sclerosis. Neuroepidemiology 23: 1-12.
13. DELALANDE, S., J. DE SEZE, D. FERRIBY, T. STOJKOVIC and P. VERMERSCH, 2002 Late onset multiple sclerosis. Rev. Neurol. 158: 1082-1087.
14. DICKSON, D. W., A. WERTKIN, Y. KRESS, H. KSIEZAK-REDING and S. H. YEN, 1990 Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab. Invest. 63: 87-99.
15. DIMITRIJEVIC, M., O. LABAN, S. VON HOERSTEN, B. M. MARKOVIC and B. D. JANKOVIC, 1994 Neonatal sound stress and development of experimental allergic encephalomyelitis in Lewis and DA rats. Int. J. Neurosci. 78: 135-143.
16. DOWDELL, K. C., D. J. CUA, E. KIRKMAN and S. A. STOHLMAN, 2003 NK cells regulate CD4 responses prior to antigen encounter. J. Immunol. 171: 234-239.
17. DYMENT, D. A., G. D. EBERS and A. D. SADOVNICK, 2004 Genetics of multiple sclerosis. Lancet Neurol. 3: 104-110.
18. EBERS, G. C., A. D. SADOVNICK, D. A. DYMENT, I. M. YEE, C. J. WILLER et al., 2004 Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 363: 1773-1774.
19. FELZIEN, L. K., J. T. MCDONALD, S.M. GLEASON, N. E. J. BERMAN and R. M. KLEIN, 2001 Increased chemokine gene expression during aging in the murine brain. Brain Res. 890: 137-146.
20. FILLMORE, P. D., M. BRACE, S. A. TROUTMAN, E. P. BLANKENHORN, S. DIEHL et al., 2003 Genetic analysis of the influence of neuroantigen-complete Freund's adjuvant emulsion structures on the sexual dimorphism and susceptibility to experimental allergic encephalomyelitis. Am. J. Pathol. 163: 1623-1632.
21. FILLMORE, P. D., E. P. BLANKENHORN, J. F. ZACHARY and C. TEUSCHER, 2004 Adult gonadal hormones selectively regulate sexually dimorphic quantitative traits observed in experimental allergic encephalomyelitis. Am. J. Pathol. 164: 167-175.
22. GIORDANO, M., and P. MOMIGLIANO-RICHIARDI, 2004 Maternal effect in multiple sclerosis. Lancet 363: 1748-1749.
23. GOOD, P., 1993 Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypotheses. Springer-Verlag, New York.
24. GOSS, J. R., C. D. FINCH and A. BJORKLUND, 1991 Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol. Aging 12: 165-170.
25. HAUS, E., and M. H. SMOLENSKY, 1999 Biologic rhythms in the immune system. Chronobiol. Int. 16: 581-622.
26. HERRERA, B. M., and G. C. EBERS, 2003 Progress in deciphering the genetics of multiple sclerosis. Curr. Opin. Neurol. 16: 253-258.
27. HOFSTETTER, H. H., R. MOSSNER, K. P. LESCH, R. A. LINKER, K. V. TOYKA et al., 2005 Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE. Clin. Exp. Immunol. 142: 39-44.
28. HOOGE, J. P., and W. K. REDEKOP, 1992 Multiple sclerosis with very late onset. Neurology 42: 1907-1910.
29. HUPPERTS, R., S. BROADLEY, A. MANDER, D. CLAYTON, D. A. S. COMPSTON et al., 2001 Patterns of disease in concordant parent-child pairs with multiple sclerosis. Neurology 57: 290-295.
30. KARED, H., A. MASSON, H. ADLE-BIASSETTE, J. F. BACH, L. CHATENOUD et al., 2005 Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4+CD25+ regulatory T-cells. Diabetes 54: 78-84.
31. KHARE, S., K. GOKULAN and D. S. LINTHICUM, 2000 Vasoactive amine responses in murine cerebrovascular endothelial cells as measured by extracellular acidification rates. J. Neurosci. Res. 60: 356-361.
32. KURTZKE, J. F., 1993 Epidemiological evidence for MS as an infection. Clin. Microbiol. Rev. 6: 382-427.
33. LABAN, O., M. DIMITRIJEVIC, S. VON HOERSTEN, B. M. MARKOVIC and B. D. JANKOVIC, 1995a Experimental allergic encephalomyelitis in adult DA rats subjected to neonatal handling or gentling. Brain Res. 676: 133-140.
34. LABAN, O., B. M. MARKOVIC, M. DIMITRIJEVIC and B. D. JANKOVIC, 1995b Maternal deprivation and early weaning modulate experimental allergic encephalomyelitis in the rat. Brain Behav. Immun. 9: 9-19.
35. LINTHICUM, D. S., and J. A. FRELINGER, 1982 Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J. Exp. Med. 156: 31-40.
36. LOCK, C., G. HERMANS, R. PEDOTTI, A. BRENDOLAN, E. SCHADT et al., 2002 Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8: 500-508.
37. MA, R. Z., J. GAO, N. D. MEEKER, P. D. FILLMORE, K. S. TUNG et al., 2002 Identification of Bphs, an autoimmune disease locus, as histamine receptor H1. Science 297: 620-623.
38. MARRA, T. R., 1984 Multiple sclerosis with onset after age 60. J. Am. Geriatr. Soc. 32: 16-18.
39. MATTIACE, L. A., P. DAVIES and D. W. DICKSON, 1990 Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am. J. Pathol. 136: 1101-1114.
40. MEEKER, N. D., W. F. HICKEY, R. KORNGOLD, W. K. HANSEN, J. D. SUDWEEKS et al., 1995 Multiple loci govern the bone marrow-derived immunoregulatory mechanism controlling dominant resistance to autoimmune orchitis. Proc. Natl. Acad. Sci. USA 92: 5684-5688.
41. MELTZER, C. C., G. SMITH, S. T. DEKOSKY, B. G. POLLOCK, C. A. MATHIS et al., 1998 Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 18: 407-430.
42. MILLER, R. A., 1996 The aging immune system: primer and prospectus. Science 273: 70-74.
43. MORGAN, T. E., I. ROZOVSKY, S. K. GOLDSMITH, D. J. STONE, T. YOSHIDA et al., 1997 Increased transcription of the astrocyte gene GFAP during middle-age is attenuated by food restriction: implications for the role of oxidative stress. Free Radic. Biol. Med. 23: 534-628.
44. MOSSNER, R., and K. P. LESCH, 1998 Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immun. 12: 249-271.
45. NANAMIYA, W., T. TAKAO, K. ASABA, E.B.DE SOUZA and K. HASHIMOTO, 2000 Effect of orchidectomy on the age-related modulation of IL-1 beta and IL-1 receptors following lipopolysaccharide treatment in the mouse. Neuroimmunomodulation 8: 13-19.
46. NICHOLS, N. R., J. R. DAY, N. J. LAPING, S. A. JOHNSON and C. E. FINCH, 1993 GFAP mRNA increases with age in rat and human brain. Neurobiol. Aging 14: 421-429.
47. NOSEWORTHY, J., D. PATY, T. WONNACOTT, T. FEASBY and G. EBERS, 1983 Multiple sclerosis after age 50. Neurology 33: 1537-1544.
48. O'CALLAGHAN, J. P., and D. B. MILLER, 1991 The concentration of glial fibrillary acid protein increases with age in the mouse and rat brain. Neurobiol. Aging 12: 171-174.
49. OGURA, K., M. OGAWA and M. YOSHIDA, 1994 Effects of ageing on microglia in the normal rat brain: immunohistochemical observations. Neuroreport 5: 1224-1226.
50. PETERS, A., K. JOSEPHSON and S. L. VINCENT, 1991 Effects of aging on the neuroglial cells and pericytes within area 17 of the rheusus monkey cerebral cortex. Anat. Rec. 229: 384-398.
51. POLLIACK, M. L., Y. BARAK and A. ACHIRON, 2001 Late-onset multiple sclerosis. J. Am. Geriatr. Soc. 49: 168-171.
52. POSER, S., N. D. RAUN and W. POSER, 1982 Age at onset, initial symptomatology and the course of multiple sclerosis. Acta Neurol. Scand. 66: 355-362.
53. ROZOVSKY, I., C. E. FINCH and T. E. MORGAN, 1998 Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation and resistance to down-regulation. Neurobiol. Aging 19: 97-103.
54. SAFRAN, A. B., 1989 Late onset multiple sclerosis: clinical pattern of optic nerve involvement. Metab. Pediatr. Syst. Ophthalmol. 12: 58-60.
55. SHEFFIELD, L. G., and N. D. BERMAN, 1998 Microglial expression of MJC class II increases in normal aging of nonhuman primates. Neurobiol. Aging 19: 47-55.
56. Sheng, J. G., R. E. Mrak and W. E. Friggin, 1998 Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol. 95: 229-234.
57. SHI, F. D., H. B. WANG, H. LI, S. HONG, M. TANIGUCHI et al., 2000 Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat. Immunol. 1: 245-251.
58. SMAALAND, R., R. B. SOTHERN, O. D. LAERUM and J. F. ABRHAMSEN, 2002 Rhythms in human bone marrow and blood cells. Chronobiol. Int. 19: 101-127.
59. SUDWEEKS, J. D., J. A. TODD, E. P. BLANKENHORN, B. B. WARDELL, S. R. WOODWARD et al., 1993 Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor beta-chain gene on mouse chromosome 6. Proc. Natl. Acad. Sci. USA 90: 3700-3704.
60. TAKAO, T., I. NAGANO, C. TOHO, T. TAKEMURA, S. MAKINO et al., 1996 Age-related reciprocal modulation of interleukin-1beta and interleukin-1 receptors in the mouse brain-endocrine-immune axis. Neuroimmunomodulation 3: 205-212.
61. TERAO, A., A. APTE-DESHPANDE, L. DOUSMAN, S. MORAIRTY, B. P. EYNON et al., 2002 Immune response gene expression increases in the aging murine hippocampus. J. Neuroimmunol. 132: 99-112.
62. TEUSCHER, C., 1985 Experimental allergic orchitis in mice. II. Association of disease susceptibility with the locus controlling Bordetella pertussis-induced sensitivity to histamine. Immunogenetics 22: 417-425.
63. TEUSCHER, C., W. F. HICKEY, C. M. GRAFER and K. S. TUNG, 1998 A common immunoregulatory locus controls susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis in BALB/c mice. J. Immunol. 160: 2751-2756.
64. TEUSCHER, C., J. Y. BUNN, P. D. FILLMORE, R. J. BUTTERFIELD, J. F. ZACHARY et al., 2004 Gender, age and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis. Am. J. Pathol. 165: 1593-1602.
65. TRAMONTIN, A. D., and E. A. BRENOWITZ, 2000 Seasonal plasticity in the adult brain. Trends Neurosci. 23: 251-258.
66. TREFOURET, S., J. P. ZAULAY, J. POUGET, J. BOUCRAUT and G. SERRATRICE, 1996 Late-onset multiple sclerosis and serum monoclonal gammopathy: An incidental association? Rev. Neurol. 152: 554-556.
67. WHITE, A. D., R. J. SWINGLER and D. A. COMPSTON, 1990 Features of multiple sclerosis in older patients in South Wales. Gerontology 36: 159-164.
68. WILLER, C. J., D. A. DYMENT, N. J. RISCH, A. D. SADOVNICK, G. D. EBERS et al., 2003 Twin concordance and sibling recurrence rates in multiple sclerosis. Proc. Natl. Acad. Sci. USA 100: 12877-12882.
69. WILLER, C. J., D. A. DYMENT, A. D. SADOVNICK, P.M. ROTHWELL, T. J. MURRAY et al., 2005 Timing of birth and risk of multiple sclerosis: population based study. BMJ 330: 120.
70. ZAVALA, F., A. MASSON, K. HADAYA, S. EZINE, F. SCHNEIDER et al., 1999 Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice. J. Immunol. 163: 5125-5132.
71. ZAVALA, F., S. ABAD, S. EZINE, V. TAUPIN, A. MASSON et al., 2002 G-CSF therapy on ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J. Immunol. 168: 2011-2019.
72. ZHOU, D., and S. CHEN, 2001 PNRC2 is a 16 kDa coactivator that interacts with nuclear receptors through an SH3-binding motif. Nucleic Acids Res. 29: 3939-3948.